Freestone Grove Partners’s Tenet Healthcare THC Stock Holding History
Bought
Maintained
Sold
Other funds holding THC
VPM
VCM
LPC
Freestone Grove Partners's THC Position: Q1 2026 in Review
Freestone Grove Partners opened a new position in Tenet Healthcare (THC) in Q1 2026: 104,187 shares worth $19.7M. The stake represents 0.14% of the portfolio and ranks #211 among its holdings. This is a return to the name: Freestone Grove Partners previously reported a position in THC as recently as Q3 2025.
Freestone Grove Partners first reported a position in THC in Q1 2025 and has held it in 4 quarters since. The position peaked at $40.1M in Q2 2025. 690 funds tracked by Wall St. Rank hold THC as of Q1 2026.
- Freestone Grove Partners held 104,187 shares of Tenet Healthcare worth $19.7M as of Q1 2026.
- Tenet Healthcare was a new Freestone Grove Partners position in Q1 2026.
- Tenet Healthcare made up 0.14% of Freestone Grove Partners's portfolio in Q1 2026, its #211 holding.
- Freestone Grove Partners first reported a position in Tenet Healthcare in Q1 2025 and has held it in 4 quarters since.
- Freestone Grove Partners's Tenet Healthcare position peaked at $40.1M in Q2 2025.
- 690 funds tracked by Wall St. Rank held Tenet Healthcare as of Q1 2026.
Based on Freestone Grove Partners's 13F filing for Q1 2026, filed 15 May 2026.